Generic

Business & Finance News

Teva’s Generic EpiPen No Less Expensive Than Mylan’s Version
Approvals News

Teva’s Generic HIV Drug Gains FDA Approval
Life Science News

Generic EpiPen Hits CVS Shelves at Just Over $100 for Two-Pack
Life Science News

Mylan Launches Generic EpiPen Priced at $300 for a Two-Pack
Blogs

Six Proposed Changes To The Medicare Part B Drug Payment Model
Blogs

FDA Fights Back Against Price Gouging
Biotech News

Charity Opposes Pfizer’s Indian Patent On Pneumonia Vaccine
Biotech News

GlaxoSmithKline Receives $54.4 Million Fine In UK For Pay-For-Delay Deal
Life Science News

Generic OxyContin On Horizon As Patents Don’t Hold Up In Court
Business & Finance News

Teva and Takeda Partner To Meet Demand For Generics In Japan
Business & Finance News

Turing Pharmaceuticals Won’t Budge on Price of Daraprim
Biotech News

Pfizer Finalizes Acquisition of Hospira
Life Science News

EU Bans 700 Generic Drugs Manufactured by India’s GVK